Pediatric depression: Neurocognitive function and treatment implications

Jennifer C. Britton; Sarah M. Kennedy; Ilana Seager; Alexander H. Queen; Michael V. Hernandez; Carolyn N. Spiro; Jill Ehrenreich-May

doi:10.4324/9780203507131-17

Pediatric depression: Neurocognitive function and treatment implications

Jennifer C. Britton, Sarah M. Kennedy, Ilana Seager, Alexander H. Queen, Michael V. Hernandez, Carolyn N. Spiro, Jill Ehrenreich-May

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Major depressive disorder (MDD) is common in children and adolescents, affecting up to 2 percent of children and 4 percent to 7 percent of adolescents in a given year (Costello et al., 2002). Pediatric depression negatively impacts mood, self-esteem, and daily functioning. For example, children may experience persistent sad mood, irritability, increased feelings of hopelessness, or disturbances in sleep and appetite (American Psychiatric Association, Association, 2013). The onset of MDD increases during adolescence, as compared to lower prevalence rates observed among younger children (Kessler, Avenevoli, & Ries Merikangas, 2001; Lewinsohn, Clarke, Seeley, & Rohde, 1994). Before reaching adulthood, approximately 20 percent of adolescents will have been diagnosed with MDD (Birmaher, Ryan, Williamson, Brent, & Kaufman, 1996; Birmaher, Ryan, Williamson, Brent, Kaufman, et al., 1996).

Original language	English (US)
Title of host publication	From Symptom to Synapse
Subtitle of host publication	A Neurocognitive Perspective on Clinical Psychology
Publisher	Taylor and Francis
Pages	211-246
Number of pages	36
ISBN (Electronic)	9781135046675
ISBN (Print)	9780415835862
DOIs	https://doi.org/10.4324/9780203507131-17
State	Published - Jan 1 2015
Externally published	Yes

ASJC Scopus subject areas

Psychology(all)

Access to Document

10.4324/9780203507131-17

Fingerprint Dive into the research topics of 'Pediatric depression: Neurocognitive function and treatment implications'. Together they form a unique fingerprint.

Cite this

Pediatric depression : Neurocognitive function and treatment implications. / Britton, Jennifer C.; Kennedy, Sarah M.; Seager, Ilana; Queen, Alexander H.; Hernandez, Michael V.; Spiro, Carolyn N.; Ehrenreich-May, Jill.

From Symptom to Synapse: A Neurocognitive Perspective on Clinical Psychology. Taylor and Francis, 2015. p. 211-246.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

@inbook{bec6dfbbbaab4c948a99fc594651aadd,

title = "Pediatric depression: Neurocognitive function and treatment implications",

abstract = "Major depressive disorder (MDD) is common in children and adolescents, affecting up to 2 percent of children and 4 percent to 7 percent of adolescents in a given year (Costello et al., 2002). Pediatric depression negatively impacts mood, self-esteem, and daily functioning. For example, children may experience persistent sad mood, irritability, increased feelings of hopelessness, or disturbances in sleep and appetite (American Psychiatric Association, Association, 2013). The onset of MDD increases during adolescence, as compared to lower prevalence rates observed among younger children (Kessler, Avenevoli, & Ries Merikangas, 2001; Lewinsohn, Clarke, Seeley, & Rohde, 1994). Before reaching adulthood, approximately 20 percent of adolescents will have been diagnosed with MDD (Birmaher, Ryan, Williamson, Brent, & Kaufman, 1996; Birmaher, Ryan, Williamson, Brent, Kaufman, et al., 1996).",

author = "Britton, {Jennifer C.} and Kennedy, {Sarah M.} and Ilana Seager and Queen, {Alexander H.} and Hernandez, {Michael V.} and Spiro, {Carolyn N.} and Jill Ehrenreich-May",

year = "2015",

month = jan,

day = "1",

doi = "10.4324/9780203507131-17",

language = "English (US)",

isbn = "9780415835862",

pages = "211--246",

booktitle = "From Symptom to Synapse",

publisher = "Taylor and Francis",

}

TY - CHAP

T1 - Pediatric depression

T2 - Neurocognitive function and treatment implications

AU - Britton, Jennifer C.

AU - Kennedy, Sarah M.

AU - Seager, Ilana

AU - Queen, Alexander H.

AU - Hernandez, Michael V.

AU - Spiro, Carolyn N.

AU - Ehrenreich-May, Jill

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Major depressive disorder (MDD) is common in children and adolescents, affecting up to 2 percent of children and 4 percent to 7 percent of adolescents in a given year (Costello et al., 2002). Pediatric depression negatively impacts mood, self-esteem, and daily functioning. For example, children may experience persistent sad mood, irritability, increased feelings of hopelessness, or disturbances in sleep and appetite (American Psychiatric Association, Association, 2013). The onset of MDD increases during adolescence, as compared to lower prevalence rates observed among younger children (Kessler, Avenevoli, & Ries Merikangas, 2001; Lewinsohn, Clarke, Seeley, & Rohde, 1994). Before reaching adulthood, approximately 20 percent of adolescents will have been diagnosed with MDD (Birmaher, Ryan, Williamson, Brent, & Kaufman, 1996; Birmaher, Ryan, Williamson, Brent, Kaufman, et al., 1996).

AB - Major depressive disorder (MDD) is common in children and adolescents, affecting up to 2 percent of children and 4 percent to 7 percent of adolescents in a given year (Costello et al., 2002). Pediatric depression negatively impacts mood, self-esteem, and daily functioning. For example, children may experience persistent sad mood, irritability, increased feelings of hopelessness, or disturbances in sleep and appetite (American Psychiatric Association, Association, 2013). The onset of MDD increases during adolescence, as compared to lower prevalence rates observed among younger children (Kessler, Avenevoli, & Ries Merikangas, 2001; Lewinsohn, Clarke, Seeley, & Rohde, 1994). Before reaching adulthood, approximately 20 percent of adolescents will have been diagnosed with MDD (Birmaher, Ryan, Williamson, Brent, & Kaufman, 1996; Birmaher, Ryan, Williamson, Brent, Kaufman, et al., 1996).

UR - http://www.scopus.com/inward/record.url?scp=85086539847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086539847&partnerID=8YFLogxK

U2 - 10.4324/9780203507131-17

DO - 10.4324/9780203507131-17

M3 - Chapter

AN - SCOPUS:85086539847

SN - 9780415835862

SP - 211

EP - 246

BT - From Symptom to Synapse

PB - Taylor and Francis

ER -